About Biofourmis
Biofourmis is a company based in Boston (United States) founded in 2015 by Maulik Majmudar and Kuldeep Singh Rajput. Biofourmis has raised $461 million across 6 funding rounds from investors including Aviva, CVS Health and Fangzhou Jianke. Biofourmis has completed 2 acquisitions, including Biovotion and Gaido Health. Biofourmis offers products and services including Biofourmis Platform, Hospital at Home, and Drug Development Tools. Biofourmis operates in a competitive market with competitors including Health Catalyst, CitiusTech, Azalea Health, CompuGroup Medical and IKS Health, among others.
- Headquarter Boston, United States
- Founders Maulik Majmudar, Kuldeep Singh Rajput
- Stage Unicorn
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biofourmis India Private Limited
- Date of Incorporation 08 Nov, 2017
- Jurisdiction Bangaluru, Karnataka, India
-
Annual Revenue
$11.54 M (USD)111.44as on Mar 31, 2023
-
Net Profit
$1.18 M (USD)113.75as on Mar 31, 2023
-
EBITDA
$1.97 M (USD)92.93as on Mar 31, 2023
-
Total Equity Funding
$461 M (USD)
in 6 rounds
-
Latest Funding Round
$20 M (USD), Series D
Jul 27, 2022
-
Investors
Aviva
& 13 more
-
Employee Count
Not available
-
Investments & Acquisitions
Biovotion
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biofourmis
Biofourmis offers a comprehensive portfolio of products and services, including Biofourmis Platform, Hospital at Home, and Drug Development Tools.
Platform for remote monitoring and care delivery services.
Solution enabling home-based hospital services and patient management.
Tools for managing drug life cycles and clinical trials.
People of Biofourmis
Unlock access to complete
Software Development Team
28 people
Leadership Team
13 people
Finance and Accounting
7 people
Product Management Team
4 people
Human Resources and Administration
3 people
Legal and Compliance
3 people
Customer Team
2 people
Senior Team
2 people
Unlock access to complete
Funding Insights of Biofourmis
Biofourmis has successfully raised a total of $461M across 6 strategic funding rounds. The most recent funding activity was a Series D round of $20 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Biofourmis
Biofourmis has secured backing from 14 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Aviva, CVS Health and Fangzhou Jianke.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment in technology startups focusing on compute, AI, and related innovations.
|
Locked | Locked | Locked | |
|
Private equity fund focused on global markets
|
Locked | Locked | Locked | |
|
Early-stage technology startups are invested in by Openspace Ventures.
|
Locked | Locked | Locked |
Investor details for Biofourmis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biofourmis
Biofourmis has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Biovotion and Gaido Health.
Investment portfolio details for Biofourmis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
AI-enabled early detection services for healthcare are provided.
|
Locked | Locked | 2018 | Locked | |
|
Patient health vitals are monitored remotely via Biovotion's wearable devices.
|
Locked | Locked | 2011 | Locked |
Complete acquisition details for Biofourmis
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Biofourmis
Detailed financials for Biofourmis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biofourmis Comparisons
Peer comparison for Biofourmis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biofourmis
Biofourmis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Health Catalyst, CitiusTech, Azalea Health, CompuGroup Medical and IKS Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cloud-based data analytics are provided for healthcare organizations.
|
|
| Locked | Locked | Locked |
Provider of AI solutions for clinical, operational, and business outcomes
|
|
| Locked | Locked | Locked |
EHR Platform with integrated Telehealth, Mobile health and RCM solutions for healthcare providers
|
|
| Locked | Locked | Locked |
Suite of practice management, reimbursement, laboratory and analytics solutions to healthcare providers
|
|
| Locked | Locked | Locked |
Provider of healthcare technology and services for revenue cycle management and clinical support
|
|
| Locked | Locked | Locked |
E-prescription and secure messaging solutions are offered to healthcare providers.
|
Detailed competitors of Biofourmis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biofourmis
Complete news archive for Biofourmis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biofourmis
Biofourmis was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Biofourmis is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Kuldeep Singh Rajput is the current CEO of Biofourmis. They have also founded this company.
Biofourmis is a funded company, having raised a total of $461M across 6 funding rounds to date.
Annual revenue of Biofourmis is $11.54M as on Mar 31, 2023.
Biofourmis was founded in 2015 in Boston, United States, within the healthcare sector. Cloud-based suite solutions are provided for virtual care and patient monitoring. The Biovitals product is utilized for tracking patient engagement, communication, and vital signs. Clinical workflows and electronic health records are integrated to support care coordination across organizations. Operations focus on remote monitoring and data-driven healthcare delivery.
Biofourmis's top competitors include IKS Health, Innovaccer and CompuGroup Medical.
Biofourmis offers Biofourmis Platform, Hospital at Home, and Drug Development Tools.
Biofourmis has made 2 acquisitions, including Biovotion, and Gaido Health.
Biofourmis has 14 investors. Key investors include Aviva, CVS Health, Fangzhou Jianke, General Atlantic, and Peak XV Partners.
The valuation of Biofourmis is $1.3B as of Apr 2022.